---
layout: post
title: "Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Reopening of Comment Period"
date: 2026-02-05 19:08:50 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-04591
original_published: 2020-03-06 00:00:00 +0000
significance: 8.00
---

# Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Reopening of Comment Period

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 06, 2020 00:00 UTC
**Document Number:** 2020-04591

## Summary

The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Best Practices in Drug and Biological Product Postmarket Safety Surveillance for FDA Staff; Draft Document; Availability; Establishment of Public Docket; Request for Comments" that appeared in the Federal Register of November 7, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/03/06/2020-04591/best-practices-in-drug-and-biological-product-postmarket-safety-surveillance-for-food-and-drug)
- API: https://www.federalregister.gov/api/v1/documents/2020-04591

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
